Mark D. Adams
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.1%
Papers in
-
- Antibiotic Resistance in Bacteria 43
-
- Vibrio bacteria research studies 17
- Co-authors
- J. Craig VenterAnthony R. KerlavageRobert A. BonomoChris FieldsHamilton O. SmithJenny M. KelleyMark DubnickAndrew G. Clark
- Journals
- Antimicrobial Agents and Chemotherapy (12 papers)Science (6 papers)Genomics (6 papers)Nature Genetics (6 papers)mBio (6 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark D. Adams
140 papers receiving 16.1k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Molecular Medicine 3.1k
- Endocrinology 1.6k
- Genetics 4.4k
- Pathology and Forensic Medicine 2.6k
- Molecular Biology 9.1k
Countries citing papers authored by Mark D. Adams
This map shows the geographic impact of Mark D. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Adams more than expected).
Fields of papers citing papers by Mark D. Adams
This network shows the impact of papers produced by Mark D. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Adams. The network helps show where Mark D. Adams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark D. Adams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor Hit paper breakdown → | 2024 | 81 |
| 2 | 2021 | 72 | |
| 3 | 2021 | 9 | |
| 4 | 2018 | 32 | |
| 5 | 2017 | 27 | |
| 6 | 2017 | 8 | |
| 7 | 2017 | 10 | |
| 8 | 2016 | 82 | |
| 9 | Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing | 2014 | 1 |
| 10 | 2010 | 156 | |
| 11 | 2010 | 75 | |
| 12 | 2009 | 93 | |
| 13 | 2008 | 10 | |
| 14 | A Scan for Positively Selected Genes in the Genomes of Humans and Chimpanzees Hit paper breakdown → | 2005 | 699 |
| 15 | 2001 | 59 | |
| 16 | 1999 | 15 | |
| 17 | 1996 | 34 | |
| 18 | 1995 | 268 | |
| 19 | 1993 | 25 | |
| 20 | 1991 | 1 |
About Mark D. Adams
Mark D. Adams is a scholar working on Molecular Medicine, Endocrinology, Molecular Biology, Genetics and Microbiology, having authored 142 papers that have together received 16.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (43 papers), Genomics and Phylogenetic Studies (35 papers), RNA and protein synthesis mechanisms (33 papers), Vibrio bacteria research studies (17 papers), Chromosomal and Genetic Variations (14 papers), Genomics and Chromatin Dynamics (13 papers), Bacterial Genetics and Biotechnology (9 papers) and RNA Research and Splicing (9 papers). The work is most often cited by research in Molecular Medicine (3.1k citations), Endocrinology (1.6k citations), Genetics (4.4k citations), Pathology and Forensic Medicine (2.6k citations) and Molecular Biology (9.1k citations). Mark D. Adams has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include J. Craig Venter, Anthony R. Kerlavage, Robert A. Bonomo, Chris Fields, Hamilton O. Smith, Jenny M. Kelley, Mark Dubnick, Andrew G. Clark, John J. Sninsky and Thomas J. White. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Science, Genomics, Nature Genetics and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.